RavenQuest BioMed Inc (CNSX:RQB) Industry Leading Grow Technology & Formalizing European Operations

RavenQuest BioMed Inc (CNSX:RQB) (OTCMKTS:RVVQF) (FRA:1IT) CEO George Robinson joins Midas Letter in-studio to discuss the company’s formal definitive agreement with Biocare partners for all RavenQuest’s joint venture operations located in Europe. The companies will construct cannabis cultivation facilities with planned capacity to produce 35,000 kilograms of medical cannabis initially in Portugal. The CEO also outlines the recent research partner announcement with McGill University. The license obtained from Health Canada allows for the possession and production of cannabis for research purposes. The CEO also explains the economics of the company’s trademark Orbital Garden technology, stating the company is in position to take a run at anyone in terms of cost and efficiency.

So I think what you’re going to see over the next six months is really, really good. Hitting our targets for our deliverables on cannabis sales, hitting our numbers on the consulting side as we look outside of Canada, and then you take a lot at more prospectively on what we’re going to do to actually make a very interesting company and take that technology and leverage it on a worldwide basis. That’s what’s really exciting right now, and I think most of the world has woken up to orbital gardening strategies versus a flat table environment. – George Robinson, RavenQuest BioMed CEO

Original article: RavenQuest BioMed Inc (CNSX:RQB) Industry Leading Grow Technology & Formalizing European Operations

©2019 Midas Letter. All Rights Reserved.